483
Amplion Clinical Communications, Inc.Amplion Clinical Communications, Inc. – FDA 483, Sep 8, 2021
Record Details
An FDA inspection of Amplion Clinical Communications, Inc. in Nashville, TN, a specification developer, revealed significant deficiencies in its quality system. Observations included inadequate procedures for corrective and preventive actions, complaint management, and documentation of design risk analysis. Additionally, the firm failed to adequately maintain its device master record for key components of its nurse call system.
View Company Profile
ID · 389d4dd7-6f9d-4e81-8575-4b9e65878dea
Other documents for Amplion Clinical Communications, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.